This High-Yield Stock Was Just Too Cheap Not to Buy
After shoring up its financial situation last year, this pipeline company should supply investors with a generous income stream for years to come.
3 Stocks You Can Keep Forever
These three very different companies have one thing in common: Each can continue to grow for decades to come.
Why 2018 Will Be the Year of the Smart Speaker
New estimates show just how strong consumer adoption is.
Are you one of them?
The offshore rig operator's downward trend was stopped by -- of all things -- a bankruptcy. But not its own.
One airline stock is trading for less than 7 times trailing earnings -- even though the company is likely to achieve double-digit EPS growth in 2018.
No state has ever done this before, and it could pave the way for other states to follow in its footsteps.
After growing its already lucrative payout 30% last year, this 4.6% yielder sees at least 20% annual growth for the next five years.
Both cybersecurity providers are poised for growth, but one gets the nod thanks to its strong bottom-line growth.
Demand for industrial robots is rising, with KUKA and FANUC hiking production capacity in an aim to profit from the trend of increasing factory automation.
A hotel booking initiative hasn't met with great success, but there's another juicy corner of the travel business ripe for the picking.
Analysts are looking for strong subscriber numbers from Netflix for its most recent quarter. Does that make the stock a buy?
It really all comes down to two simple factors.
The Snapchat operator's cost structure is the opposite of scalable.
Shopify has been a solid growth vehicle for investors, but these three stocks might be even better picks going forward.
Apple's services segment is benefitting from a handful of strong catalysts.
Outperforming the graphics chipmaker won't be easy, but these three stocks have what it takes.
Want to shake that debt for good? Here's how.
When it comes to picking healthcare coverage, too many of us opt for plans that don't make any financial sense.
After a sharp sell-off in recent years, these pipeline companies sell for shockingly low prices.
Did the U.S. Attorney General unknowingly give a nice present to marijuana investors? That could be the case with this marijuana stock.
Can you guess which big pharma companies each have two drugs on the list?
Hint: Despite what you might think, it's not a technology company. However, it is a household name.